Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECG changes during robotic prostatectomy with sevoflurane, desflurane, or TIVA
NCT03539003Completed
- Sponsor
- Yonsei University
- Start
- May 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sevoflurane in prostate cancer (PCa) (3 arms), sponsored by Yonsei University. Primary endpoint: heart-rate corrected QT interval. Started May 2018; status: completed.
02
Drugs
sevoflurane
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03539003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539003.